UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8977) 8977
Magazine Article (82) 82
Book Chapter (23) 23
Newsletter (9) 9
Dissertation (5) 5
Conference Proceeding (4) 4
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6813) 6813
isoniazid - therapeutic use (5944) 5944
male (3493) 3493
female (3352) 3352
science & technology (3050) 3050
tuberculosis (2965) 2965
adult (2925) 2925
antitubercular agents - therapeutic use (2860) 2860
life sciences & biomedicine (2809) 2809
isoniazid (2771) 2771
rifampin - therapeutic use (2368) 2368
tuberculosis, pulmonary - drug therapy (2153) 2153
middle aged (2114) 2114
streptomycin - therapeutic use (1464) 1464
adolescent (1431) 1431
infectious diseases (1332) 1332
biological and medical sciences (1298) 1298
tuberculosis - drug therapy (1293) 1293
drug therapy, combination (1289) 1289
old medline (1280) 1280
medical sciences (1268) 1268
abridged index medicus (1263) 1263
niacin (1228) 1228
ethambutol - therapeutic use (1221) 1221
nicotinic acids - therapeutic use (1213) 1213
aged (1135) 1135
child (1130) 1130
isoniazid - administration & dosage (981) 981
mycobacterium tuberculosis - drug effects (952) 952
pyrazinamide - therapeutic use (950) 950
isoniazid - adverse effects (878) 878
animals (828) 828
tuberculosis - prevention & control (728) 728
time factors (701) 701
isoniazid - pharmacology (672) 672
bacterial diseases (663) 663
pharmacology. drug treatments (661) 661
infant (650) 650
isomerism (646) 646
child, preschool (638) 638
treatment outcome (625) 625
aminosalicylic acids - therapeutic use (606) 606
pharmacology & pharmacy (602) 602
tuberculin test (592) 592
mycobacterium tuberculosis - isolation & purification (582) 582
tuberculosis, pulmonary - therapy (579) 579
rifampin - administration & dosage (568) 568
antitubercular agents - administration & dosage (567) 567
respiratory system (563) 563
human bacterial diseases (551) 551
drug resistance (550) 550
microbiology (543) 543
drug resistance, microbial (532) 532
rifampin (527) 527
antitubercular agents - pharmacology (515) 515
tuberculosis and atypical mycobacterial infections (487) 487
tuberculosis, pulmonary - prevention & control (479) 479
general & internal medicine (468) 468
antitubercular agents - adverse effects (460) 460
mycobacterium tuberculosis (460) 460
antibiotics. antiinfectious agents. antiparasitic agents (446) 446
risk factors (434) 434
drug therapy (431) 431
tuberculosis, multidrug-resistant - drug therapy (424) 424
microbial sensitivity tests (421) 421
tuberculosis, pulmonary - microbiology (401) 401
follow-up studies (393) 393
medicine, general & internal (391) 391
research article (375) 375
immunology (369) 369
sputum - microbiology (368) 368
young adult (366) 366
tuberculosis - epidemiology (360) 360
retrospective studies (359) 359
antibacterial agents (352) 352
mice (349) 349
rifampin - adverse effects (345) 345
rifampin - pharmacology (334) 334
antitubercular agents (330) 330
tuberculosis, pulmonary - diagnosis (327) 327
antibiotics, antitubercular - therapeutic use (314) 314
tuberculosis - diagnosis (307) 307
tuberculosis, pulmonary - epidemiology (296) 296
radiography (293) 293
tuberculosis, pulmonary - complications (289) 289
health aspects (287) 287
aids/hiv (280) 280
medicine (278) 278
research (274) 274
mycobacterium tuberculosis - genetics (271) 271
pyrazinamide (268) 268
drugs (265) 265
analysis (264) 264
hiv (264) 264
care and treatment (261) 261
drug combinations (261) 261
hiv infections - complications (258) 258
pyrazinamide - administration & dosage (254) 254
drug administration schedule (253) 253
infections (252) 252
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7044) 7044
French (481) 481
Russian (458) 458
German (441) 441
Spanish (220) 220
Italian (207) 207
Japanese (118) 118
Polish (111) 111
Portuguese (68) 68
Chinese (38) 38
Dutch (23) 23
Romanian (21) 21
Hungarian (19) 19
Norwegian (16) 16
Turkish (12) 12
Swedish (11) 11
Czech (10) 10
Bulgarian (9) 9
Croatian (9) 9
Danish (9) 9
Hebrew (8) 8
Finnish (6) 6
Serbian (6) 6
Ukrainian (4) 4
Korean (3) 3
Slovak (3) 3
Lithuanian (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet infectious diseases, ISSN 1473-3099, 2016, Volume 17, Issue 1, pp. 39 - 49
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 1/2013, Volume 207, Issue 1, pp. 9 - 17
Epidemics | Ferries | BACTERIA | Tuberculosis | Disease transmission | Mycobacterium tuberculosis | HIV | Hospital admissions | Data transmission | Multidrug resistant tuberculosis | Infection control | Genotyping | Drug resistance | Transmission | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Biological and medical sciences | Infectious diseases | Medical sciences | Prevalence | Humans | Male | Cross Infection - complications | Cross Infection - transmission | Adult | Extensively Drug-Resistant Tuberculosis - microbiology | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Cross Infection - epidemiology | Extensively Drug-Resistant Tuberculosis - complications | Mycobacterium tuberculosis - classification | HIV Infections - virology | South Africa - epidemiology | Genotype | Sequence Analysis, DNA | Mycobacterium tuberculosis - isolation & purification | Pyrazinamide - therapeutic use | Extensively Drug-Resistant Tuberculosis - epidemiology | Hospitals, Rural | Polymorphism, Restriction Fragment Length | Extensively Drug-Resistant Tuberculosis - transmission | Cross Infection - microbiology | HIV Infections - complications | Mutation | Cluster Analysis | Mycobacterium tuberculosis - genetics | Extensively drug-resistant tuberculosis | Distribution | Reports | Cross infection | Research | Nosocomial infections | Risk factors | Index Medicus | Abridged Index Medicus | Major and Brief Reports | transmission | drug resistance | tuberculosis | genotyping
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2013, Volume 57, Issue 2, pp. 1019 - 1024
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Tuberculosis and atypical mycobacterial infections | Viral diseases | Biological and medical sciences | Medical sciences | Immunodeficiencies | Infectious diseases | Bacterial diseases | Human bacterial diseases | Pharmacology. Drug treatments | Viral diseases of the lymphoid tissue and the blood. Aids | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Oxidoreductases, N-Demethylating - genetics | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Tuberculosis - complications | Male | Tenofovir | Young Adult | Drug Interactions | Adenine - therapeutic use | Tuberculosis - drug therapy | Lamivudine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Benzoxazines - blood | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Anti-HIV Agents - blood | Reverse Transcriptase Inhibitors - therapeutic use | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | HIV Infections - blood | Pharmacogenetics | Adenine - analogs & derivatives | Organophosphonates - therapeutic use | Genotype | Pyrazinamide - therapeutic use | Benzoxazines - therapeutic use | Adolescent | HIV Infections - complications | HIV Infections - drug therapy | Polymorphism, Single Nucleotide | Cytochrome P-450 CYP2B6 | Index Medicus | Body weight | Clinical Therapeutics
Journal Article
Journal Article
Journal of neuro-oncology, ISSN 0167-594X, 3/2009, Volume 92, Issue 1, pp. 33 - 35
Oncology | Opportunistic infections | Temozolomide | Medicine & Public Health | Lymphopenia | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Dacarbazine - adverse effects | Red-Cell Aplasia, Pure - drug therapy | Heptanoic Acids - therapeutic use | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Tuberculosis, Pulmonary - drug therapy | Tuberculosis, Pulmonary - chemically induced | Dacarbazine - analogs & derivatives | Anti-Inflammatory Agents - therapeutic use | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Fluoxetine - therapeutic use | Pyrroles - therapeutic use | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Anti-Infective Agents - therapeutic use | Anticonvulsants - therapeutic use | Combined Modality Therapy | Trimethoprim, Sulfamethoxazole Drug Combination - therapeutic use | Brain Neoplasms - drug therapy | Radiotherapy | Pyrazinamide - therapeutic use | Atorvastatin Calcium | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Phenobarbital - therapeutic use | Anticholesteremic Agents - therapeutic use | Antibiotics, Antitubercular - therapeutic use | Antineoplastic Agents, Alkylating - adverse effects | Glioblastoma - drug therapy | Prednisone - therapeutic use | Online health care information services | Pneumonia | Tuberculosis | Gliomas | Analysis | Bacterial pneumonia | Brain tumors | Pyrazinamide | Health aspects | Rifampin | Index Medicus
Journal Article